Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
18
|
37
|
0.500 |
None |
0.977 |
6 |
4
|
2008 |
2020 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
2
|
3
|
0.500 |
None |
0.961 |
1 |
1
|
2009 |
2020 |
Nonalcoholic Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
2
|
3
|
0.500 |
None |
1.000 |
1 |
1
|
2008 |
2020 |
Liver Cirrhosis, Alcoholic
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
3
|
4
|
0.500 |
None |
0.917 |
1 |
1
|
2010 |
2019 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
67
|
119
|
0.400 |
None |
0.933 |
1 |
1
|
2001 |
2019 |
Liver Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
9
|
13
|
0.200 |
None |
0.932 |
1 |
1
|
2011 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
16
|
24
|
0.200 |
None |
0.941 |
1 |
1
|
2011 |
2020 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
353
|
844
|
0.200 |
None |
0.895 |
1 |
1
|
2009 |
2019 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
65
|
0.110 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Serum Alanine Aminotransferase Measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
10 |
8
|
2008 |
2019 |
Alanine aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
10 |
8
|
2008 |
2019 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
4 |
4
|
2010 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
308
|
766
|
0.100 |
None |
1.000 |
4 |
4
|
2017 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
3
|
2016 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
633
|
1159
|
0.100 |
None |
1.000 |
3 |
3
|
2016 |
2019 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
3
|
2016 |
2019 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
254
|
550
|
0.100 |
None |
1.000 |
2 |
5
|
2019 |
2019 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
264
|
456
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2018 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
324
|
837
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
250
|
495
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Portal cirrhosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
3
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
353
|
951
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
623
|
1003
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
129
|
209
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |